John Tilton, Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 104,000 shares at $67.53 ($7.0M) on 2020-06-10, disclosed to the SEC on 2020-06-12.
Open-market sale of $7.0M BHVN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.70 | 21,364 | $1.4M | 20.3% |
| 2 | $66.70 | 21,364 | $1.4M | 20.3% |
| 3 | $67.53 | 22,838 | $1.5M | 22.0% |
| 4 | $67.53 | 22,838 | $1.5M | 22.0% |
| 5 | $68.57 | 5,331 | $366K | 5.2% |
| 6 | $68.57 | 5,331 |
| $366K |
| 5.2% |
| 7 | $69.40 | 2,467 | $171K | 2.4% |
| 8 | $69.40 | 2,467 | $171K | 2.4% |
| Total | $67.38 avg | 104,000 | $7.0M | 100% |
| Filing → |
| BHVN | SELL | 2017-11-02 | $878K | — | Filing → |